← All organizations
Highest phase reached
Phase 3
First clinical trial
May 1, 2013Last known activity
Dec 15, 2020
Timeline
2000s
- Jun 1, 2005
Prolong Pharmaceuticals— Founded
Drugs by trial phase (5 distinct, 14 trials)
Phase 3 (2 own, 0 via acquisition)
Phase 2 (1 own, 0 via acquisition)
Phase 1 (2 own, 0 via acquisition)
Indications
Recent trials (22)
- NCT04677777Lead sponsorPhase 1Dec 15, 2020
- NCT03559387Lead sponsorPhase 2Aug 8, 2017
- NCT02950857Lead sponsorPhase 1Dec 1, 2016
- NCT02950857Study directorPhase 1Dec 1, 2016
- NCT02411708Study directorPhase 2Nov 1, 2016
- NCT02411708Lead sponsorPhase 2Nov 1, 2016
- NCT02672540Study directorPhase 2Aug 1, 2016
- NCT02672540Lead sponsorPhase 2Aug 1, 2016
- NCT02658162Study directorPhase 2Jun 1, 2016
- NCT02658162Lead sponsorPhase 2Jun 1, 2016
- NCT02600390Lead sponsorPhase 2Mar 1, 2016
- NCT02754999Study directorPhase 1Mar 1, 2016
- NCT02754999Lead sponsorPhase 1Mar 1, 2016
- NCT02600390Study directorPhase 2Mar 1, 2016
- NCT02533362Lead sponsorPhase 1/Phase 2Oct 1, 2015
Details
- Founded
- South Plainfield, NJ, US Jun 1, 2005
- Last known activity
- Dec 15, 2020